Atezolizumab plus tivozanib for immunologically cold tumor types: the IMMCO-1 trial

Ramnaraign, BH; Lee, JH; Ali, A; Rogers, SC; Fabregas, JC; Thomas, RM; Allegra, CJ; Sahin, I; DeRemer, DL; George, TJ; Chatzkel, JA

Ramnaraign, BH (通讯作者)，Univ Florida, Dept Med, 1600 SW Archer Rd, Gainesville, FL 32608 USA.

FUTURE ONCOLOGY, 2022; 18 (34): 3815

Abstract

Immune checkpoint inhibitor therapy represents a significant advance in cancer care. The interaction between PD-1 and PD-L1 induces immune tolerance a......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索